Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Reduce infections caused by Campylobacter — FS‑01 Data Methodology and Measurement

About the National Data

Data

Baseline: 16.2 laboratory-diagnosed, domestically-acquired Campylobacter infections per 100,000 population occurred on average annually in 2016-18

Target: 10.9 per 100,000

Numerator
Number of laboratory-diagnosed, domestically-acquired cases of illness caused by Campylobacter reported to FoodNet.
Denominator
Number of persons in FoodNet surveillance area.
Target-setting method
Maintain consistency with national programs, regulations, policies, or laws
Target-setting method justification
The target was selected to align with the regulation: "New Performance Standards for Salmonella and Campylobacter in Not-Ready-to-Eat Comminuted Chicken and Turkey Products and Raw Chicken Parts and Changes to Related Agency Verification Procedures: Response to Comments and Announcement of Implementation Schedule" (Federal Register 81 FR 7285 February 11, 2016, pages 7285-7300), which used a target-setting method of modeling.

Methodology

Methodology notes

FoodNet conducts active population-based surveillance in 10 U.S. states for all laboratory-diagnosed infections with select enteric pathogens transmitted commonly through food. Campylobacter, Listeria, Salmonella, Shiga toxin-producing Escherichia coli (STEC) O157 and non-O157, Shigella, Vibrio, and Yersinia infections are diagnosed by laboratory testing of samples from patients. FoodNet personnel regularly contact clinical laboratories to ascertain laboratory-diagnosed cases of infection occurring within the surveillance sites. Hospitalizations occurring within 7 days of specimen collection date are recorded, as is the patient's status at hospital discharge or 7 days after the specimen collection date if not hospitalized. Deaths and hospitalizations are attributed to the pathogen if they occur within 7 days of the specimen collection date regardless of actual cause. International travel occurring within 7 days of illness onset is recorded. The pathogen is considered domestically acquired if no travel occurred within 7 days of illness onset regardless of actual cause.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective FS-1.1 in that objective FS-1.1 tracked the number of culture-confirmed cases of Campylobacter infections, while this objective tracks domestically acquired Campylobacter infections, both culture-confirmed and those identified through culture-independent diagnostic tests (CIDTs).
Revision History
Revised. 

In 2021, the original baseline was revised from 15.8 to 16.2 due to a data update that changed the baseline years from 2015-2017 to 2016-2018. The target was adjusted from 10.6 to 10.9 to reflect the revised baseline using the original target-setting method.